📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Meta Platforms must face medical privacy class action

Published 09/11/2023, 11:13 AM
Updated 09/11/2023, 11:17 AM
© Reuters. A logo of Meta Platforms Inc. is seen at its booth, at the Viva Technology conference dedicated to innovation and startups, at Porte de Versailles exhibition center in Paris, France June 17, 2022. REUTERS/Benoit Tessier

By Jonathan Stempel

(Reuters) - A U.S. federal judge said Meta Platforms (NASDAQ:META) must face a lawsuit claiming that it violated the medical privacy of patients who were treated by hospitals and other healthcare providers that used its Meta Pixel tracking tool.

U.S. District Judge William Orrick in San Francisco said the plaintiffs could pursue claims that Meta violated a federal wiretap law and a California privacy law, and violated its own contractual promises governing user privacy on Facebook.

In a 26-page decision on Thursday, the judge said the case, based on the evidence so far, "does not negate the plausible allegations that sensitive healthcare information is intentionally captured and transmitted to Meta."

Orrick dismissed some other claims but said the plaintiffs, all using John Doe or Jane Doe pseudonyms, could try to replead them.

According to the plaintiffs, Meta Pixel provided sensitive information about their health to Meta when they logged into patient portals, where the tracking tool had been installed, enabling Meta to make money from targeted advertising.

The lawsuit seeks unspecified damages for all Facebook users whose health information was obtained by Meta.

Neither Meta nor lawyers for the Menlo Park, California-based company responded on Friday to requests for immediate comment. Lawyers for the plaintiffs did not immediately respond to similar requests.

When the litigation began in June 2020, lawyers for one plaintiff said they had found at least 664 hospitals and other healthcare providers that used Meta Pixel.

In seeking a dismissal, Meta said it "does not disagree" that sending sensitive health information could be a serious problem.

But it also said there was nothing inherently harmful or unlawful about its technology, and that it was up to the healthcare providers to decide how to use Meta Pixel.

Orrick, however, said it was not clear whether Meta did enough to stop the transmission of patient details, or might be excused because healthcare providers actually consented to it.

© Reuters. A logo of Meta Platforms Inc. is seen at its booth, at the Viva Technology conference dedicated to innovation and startups, at Porte de Versailles exhibition center in Paris, France June 17, 2022. REUTERS/Benoit Tessier

He also found "detailed and plausible allegations" that transmitting such information was necessary for Meta's advertising services.

The case is In re Meta Pixel Healthcare Litigation, U.S. District Court, Northern District of California, No. 22-03580.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.